Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Article
  • Published:

High-efficiency plasmid gene transfer into dystrophic muscle

Abstract

The efficiency of plasmid gene transfer in skeletal muscle is significantly enhanced by pretreatment with hyaluronidase and the application of an electrical field to the muscle following the injection of plasmid DNA, a process referred to as electrotransfer. However, the presence of increased levels of connective tissue in muscular dystrophies, such as Duchenne muscular dystrophy (DMD), may affect the efficiency of this process. Here we demonstrate that the efficiency of electrotransfer is not affected by increased levels of connective tissue in the mdx mouse model of DMD and that any damage induced by the electrotransfer process is not exacerbated in the dystrophic phenotype. However, increasing the concentration of hyaluronidase does not improve transfection efficiencies further. Unlike direct injection of plasmid DNA, the efficiency of electrotransfer is not dependent upon the sex and age of mice used. The combined treatment of hyaluronidase and electrotransfer results in highly efficient gene transfer in dystrophic muscle with limited muscle damage.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  1. Acsadi G et al. Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs. Nature 1991; 352: 815–881.

    CAS  PubMed  Google Scholar 

  2. Wolff JA et al. Direct gene transfer into mouse muscle in vivo. Science 1990; 247(Part 1): 1465–1468.

    Article  CAS  PubMed  Google Scholar 

  3. Davis HL, Whalen RG, Demeneix BA . Direct gene transfer into skeletal muscle in vivo: factors affecting efficiency of transfer and stability of expression. Hum Gene Ther 1993; 4: 151–159.

    Article  PubMed  Google Scholar 

  4. Levy MY et al. Characterization of plasmid DNA transfer into mouse skeletal muscle: evaluation of uptake mechanism expression and secretion of gene products into blood. Gene Ther 1996; 3: 201–211.

    CAS  PubMed  Google Scholar 

  5. Manthorpe M et al. Gene therapy by intramuscular injection of plasmid DNA: studies on firefly luciferase gene expression in mice. Hum Gene Ther 1993; 4: 419–431.

    Article  CAS  PubMed  Google Scholar 

  6. Wells DJ, Goldspink G . Age and sex influence expression of plasmid DNA directly injected into mouse skeletal muscle. FEBS Lett 1992; 306: 203–205.

    Article  CAS  PubMed  Google Scholar 

  7. Wells DJ et al. Evaluation of plasmid DNA for in vivo gene therapy: factors affecting the number of transfected fibers. J Pharm Sci 1998; 87: 763–768.

    Article  CAS  PubMed  Google Scholar 

  8. Mathiesen I . Electropermeabilization of skeletal muscle enhances gene transfer in vivo. Gene Ther 1999; 6: 508–514.

    Article  CAS  PubMed  Google Scholar 

  9. Mir LM et al. Long-term, high level in vivo gene expression after electric pulse-mediated gene transfer into skeletal muscle. C R Acad Sci III 1998; 321: 893–899.

    Article  CAS  PubMed  Google Scholar 

  10. Aihara H, Miyazaki J . Gene transfer into muscle by electroporation in vivo. Nat Biotechnol 1998; 16: 867–870.

    Article  CAS  PubMed  Google Scholar 

  11. Vilquin J et al. Electrotransfer of naked DNA in the skeletal muscles of animal models of muscular dystrophies. Gene Ther 2001; 8: 1097–1107.

    Article  CAS  PubMed  Google Scholar 

  12. McMahon JM et al. Optimisation of electrotransfer of plasmid into skeletal muscle by pretreatment with hyaluronidase – increased expression with reduced muscle damage. Gene Ther 2001; 8: 1264–1270.

    Article  CAS  PubMed  Google Scholar 

  13. Vicat JM et al. Muscle transfection by electroporation with high-voltage and short-pulse currents provides high-level and long-lasting gene expression. Hum Gene Ther 2000; 11: 909–916.

    Article  CAS  PubMed  Google Scholar 

  14. Mennuni C et al. Hyaluronidase increases electrogene transfer efficiency in skeletal muscle. Hum Gene Ther 2002; 13: 355–365.

    Article  CAS  PubMed  Google Scholar 

  15. Danko I et al. High expression of naked plasmid DNA in muscles of young rodents. Hum Mol Genet 1997; 6: 1435–1443.

    Article  CAS  PubMed  Google Scholar 

  16. Jooss K, Turka LA, Wilson JM . Blunting of immune responses to adenoviral vectors in mouse liver and lung with CTLA4Ig. Gene Ther 1998; 5: 309–319.

    Article  CAS  PubMed  Google Scholar 

  17. Halbert CL et al. Successful readministration of adeno-associated virus vectors to the mouse lung requires transient immunosuppression during the initial exposure. J Virol 1998; 72: 9795–9805.

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Mir LM et al. High-efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc Natl Acad Sci USA 1999; 96: 4262–4267.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Coulton GR et al. The mdx mouse skeletal muscle myopathy: I. A histological, morphometric and biochemical investigation. Neuropathol Appl Neurobiol 1988; 14: 53–70.

    Article  CAS  PubMed  Google Scholar 

  20. Budker V et al. Hypothesis: naked plasmid DNA is taken up by cells in vivo by a receptor-mediated process. J Gene Med 2000; 2: 76–88.

    Article  CAS  PubMed  Google Scholar 

  21. Satkauskas S et al. Slow accumulation of plasmid in muscle cells: supporting evidence for a mechanism of DNA uptake by receptor-mediated endocytosis. Mol Ther 2001; 4: 317–323.

    Article  CAS  PubMed  Google Scholar 

  22. Somiari S et al. Theory and in vivo application of electroporative gene delivery. Mol Ther 2000; 2: 178–187.

    Article  CAS  PubMed  Google Scholar 

  23. Vincent N et al. Long-term correction of mouse dystrophic degeneration by adenovirus-mediated transfer of a minidystrophin gene. Nat Genet 1993; 5: 130–134.

    Article  CAS  PubMed  Google Scholar 

  24. Deconinck N et al. Functional protection of dystrophic mouse (mdx) muscles after adenovirus-mediated transfer of a dystrophin minigene. Proc Natl Acad Sci USA 1996; 93: 3570–3574.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Clemens PR et al. In vivo muscle gene transfer of full-length dystrophin with an adenoviral vector that lacks all viral genes. Gene Ther 1996; 3: 965–972.

    CAS  PubMed  Google Scholar 

  26. Jiao S et al. Direct gene transfer into nonhuman primate myofibers in vivo. Hum Gene Ther 1992; 3: 21–33.

    Article  CAS  PubMed  Google Scholar 

  27. Ferrer A . PhD thesis, University of London, 2001.

    Google Scholar 

  28. Ferrer A, Wells KE, Wells DJ . Immune responses to dystropin: implications for gene therapy of Duchenne muscular dystrophy. Gene Ther 2000; 7: 1439–1446.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank George Dickson (Royal Holloway, London) and Jim Owen (Royal Free Hospital, London) for the loan of the BTX electroporator and electrodes. This work was funded by the Medical Research Council of Great Britain, the Muscular Dystrophy Campaign and the Wellcome Trust.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gollins, H., McMahon, J., Wells, K. et al. High-efficiency plasmid gene transfer into dystrophic muscle. Gene Ther 10, 504–512 (2003). https://doi.org/10.1038/sj.gt.3301927

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3301927

Keywords

This article is cited by

Search

Quick links